Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials

Pain Physician

Volumn 11, Issue 6, 2008, Pages 717-773

  Manchikanti, Laxmaiah ^a,d   Hirsch, Joshua A ^b,e   Smith, Howard S ^c  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d University of Louisville School of Medicine   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allocation concealment; Blinding; Consolidated standards of reporting trials (CONSORT) statement; Minimal clinical important difference (MCID); Minimal clinically important change (MCIC); Placebo controlled trial; Pragmatic controlled trial; Randomization; Randomized controlled trial (RCT); Sample size

Indexed keywords

BETAMETHASONE; PLACEBO;

ARTHROSCOPIC SURGERY; CHECKLIST; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EFFECT SIZE; EVIDENCE BASED MEDICINE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAWTHORNE EFFECT; HEALTH CARE QUALITY; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; KNEE OSTEOARTHRITIS; MEDICAL ETHICS; METHODOLOGY; NECK PAIN DISABILITY INDEX; NONPARAMETRIC TEST; OPEN STUDY; OSWESTRY DISABILITY INDEX; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARAMETER; PARAMETRIC TEST; PATIENT PARTICIPATION; PATIENT SAFETY; PLACEBO EFFECT; PRACTICE GUIDELINE; QUALITY CONTROL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELIABILITY; REVIEW; ROLAND MORRIS DISABILITY QUESTIONNAIRE; SAMPLE SIZE; SCORING SYSTEM; SHORT FORM 36; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VALIDITY; VISUAL ANALOG SCALE; CLINICAL PROTOCOL; EPIDEMIOLOGY; PAIN; STANDARD;

BIAS (EPIDEMIOLOGY); CLINICAL PROTOCOLS; DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; PAIN; PLACEBOS; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 64049119807     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (527)

1. Guyatt G, Drummond R. Part 1. The Basics: Using the Medical Literature. 1A. Introduction: The philosophy of evidence-based medicine. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 3-12.
2. Napodano RJ. Values in Medical Practice. Human Sciences Press, New York, 1986.
3. Haynes RB, Sackett RB, Gray JM, Cook DC, Guyatt GH. Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club 1996; 125:A14-A16.
4. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled trial: Clinical usefulness. Our three-year experience. Ann Intern Med 1990; 112:293-299.
5. Larson EB, Ellsworth AJ. Randomized clinical trials in single patients during a 2-year period. JAMA 1993; 270:2708-2712.
6. Guyatt G, Drummond R. Part 2. The Basics: Using and Teaching the Principles of Evidence-Based Medicine. 2B1. Therapy and validity. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 247-308.
7. Mahon J, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. BMJ 1996; 312:1069-1074.
8. Nisbett R, Ross L. Human Inference. Prentice-Hall, Englewood Cliffs, 1980.
9. Guyatt G, Drummond R. Part 1. The Basics: Using the Medical Literature. 1C2. Diagnostic tests. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 121-140.
10. Hotopf M. The pragmatic randomized controlled trial. Adv Psychiatr Treat 2002; 8:326-333.
11. Williams DD, Garner J. The case against 'the evidence': A different perspective on evidence-based medicine. Br J Psychiatry 2002; 180:8-12.
12. Hotopf M, Lewis G, Normand C. Putting trials on trial: The costs and consequences of small trials in depression: A systematic review of methodology. J Epidemiol Community Health 1997; 51:354-358.
13. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317:1181-1184.
14. Hotopf M, Churchill R, Lewis G. Pragmatic randomized controlled trials in psychiatry. Br J Psychiatry 1999; 175:217-223.
15. Miles A, Charlton B, Bentley P, Polychronis A, Grey J, Price N. New perspectives in the evidence-based healthcare debate. J Eval Clin Pract 2000; 6:77-84.
16. Healy D. Randomized Controlled Trials: Evidence Biased Psychiatry. Alliance for Human Research Protection, 2002. www.ahrp.org/COI/healy0802.php
17. Fisher RA. The arrangement of field experiments. J Ministry Ag 1926; 33:503-513.
18. Amberson JB, McMahon BT, Pinner MA. Clinical trial of sanocrysin in pulmonary tuberculosis. Am Rev Tuberc 1931;24:401-435.
19. Marshall G, Blacklock JWS, Cameron C, Capon NB, Cruickshank R, Gaddum JH, Heaf FRG, Hill AB, Houghton LE, Hoyle JC, Raistrick H, Scadding JG, Tytler WH, Wilson GW, Hart P. Streptomycin treatment of pulmonary tuberculosis: A Medical Research Council investigation. BMJ 1948; 2:769-782.
20. American College of Occupational and Environmental Medicine (ACOEM) Low back Disorders. In Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. American College of Occupational and Environmental Medicine Press, Elk Grove Village, 2007.
21. American College of Occupational and Environmental Medicine (ACOEM) Chronic Pain. In Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. OAmerican College of Occupational and Environmental Medicine Press, Elk Grove Village, awaiting publication.
22. Manchikanti L, Singh V, Derby R, Schultz DM, Benyamin RM, Prager JP, Hirsch JA. Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management. Pain Physician 2008; 11:393-482.
23. Manchikanti L, Singh V, Derby R, Helm S, Trescot AM, Staats PS, Prager JP, Hirsch JA. Review of occupational medicine practice guidelines for interventional pain management and potential implications. Pain Physician 2008; 11:271-289.
24. Manchikanti L, Singh V, Helm S, Trescot AM, Hirsch JA. A critical appraisal of 2007 American College of Occupational and Environmental Medicine (ACOEM) practice guidelines for interventional pain management: An independent review utilizing AGREE, AMA, IOM, and other criteria. Pain Physician 2008; 11:291-310.
25. Chou R. Using evidence in pain practice: Part I: Assessing quality of systematic reviews and clinical practice guidelines. Pain Med 2008; 9:518-530.
26. Chou R. Using evidence in pain practice: Part II: Interpreting and applying systematic reviews and clinical practice guidelines. Pain Med 2008; 9:531-541.
27. Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L. Interventional techniques: Evidencebased practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10:7-111.
28. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low-back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995; 63:279-288.
29. Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: An evidence-based approach. J Back Musc Rehabil 1999; 13:47-58.
30. van Tulder MWV, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine 1997; 22:2128-2156.
31. Nelemans PJ, Debie RA, DeVet HC, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Spine 2001; 26:501-515.
32. Geurts JW, van Wijk RM, Stolker RJ, Groen GJ. Efficacy of radiofrequency procedures for the treatment of spinal pain: A systematic review of randomized clinical trials. Reg Anesth Pain Med 2001; 26:394-400.
33. Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, Mummaneni P, Watters WC 3rd, Wang J, Walters BC, Hadley MN; American Association of Neurological Surgeons/Congress of Neurological Surgeons. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: injection therapies, lowback pain, and lumbar fusion. J Neurosurg Spine 2005; 2:707-715.
34. Niemisto L, Kalso E, Malmivaara A, Seitsalo S, Hurri H. Cochrane Collaboration Back Review Group. Radiofrequency denervation for neck and back pain: A systematic review within the framework of the Cochrane collaboration back review group. Spine 2003, 28:1877-1888.
35. Levin JH. Prospective, double-blind, randomized placebo-controlled trials in interventional spine: What the highest quality literature tells us. Spine J 2008; Sep 11 [Epub ahead of print].
36. Bigos SJ, Boyer OR, Braen GR, Brown K, Deyo R. Acute Low Back Problems in Adults. Clinical Practice Guideline Number 4. AHCPR Publication No. 95-0642. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, Rockville, December 1994.
37. Carragee EJ, Hurwitz EL, Cheng I, Carroll LJ, Nordin M, Guzman J, Peloso P, Holm LW, Côté P, Hogg-Johnson S, van der Velde G, Cassidy JD, Haldeman S, Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Treatment of neck pain: Injections and surgical interventions: Results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008; 33:S153-S169.
38. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G. Chapter 4: European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006; 15:S192-S300.
39. Armon C, Argoff CE, Samuels J, Backonja MM; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007; 68:723-729.
40. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. Int J Prosthodont 2006; 19:126-128.
41. Kao LS, Tyson JE, Blakely ML, Lally KP. Clinical research methodology I: Introduction to randomized trials. J Am Coll Surg 2008; 206:361-369.
42. World Health Organization. International Clinical Trials Registry Platform (ICTRP). 2007. www.who.int/entity/ictrp/en/
43. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999; 23:1210-1214.
44. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery 1994; 115:707-712.
45. Hardin WD Jr, Stylianos S, Lally KP. Evidence-based practice in pediatric surgery. J Pediatr Surg 1999; 34:908-912.
46. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: Problems and possible solutions. BMJ 2002; 324:1448-1451.
47. Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, Frei III E. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 1992; 10:102-110.
48. Farquhar C, Marjoribanks J, Basser R, Hetrick S, Lethaby A. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 2005; CD003142.
49. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6:1368-1376.
50. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313:1191-1200.
51. Weinstein PR, Rodriguez Y, Baena R, Chater NL. Results of extracranial-intracranial arterial bypass for intracranial internal carotid artery stenosis: Review of 105 cases. Neurosurgery 1984; 15:787-794.
52. Solomon MJ, McLeod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 1995; 118:459-467.
53. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 2005; 140:584-589.
54. Balasubramanian SP, Wiener M, Alshameeri Z, Tiruvoipati R, Elbourne D, Reed MW. Standards of reporting of randomized controlled trials in general surgery: Can we do better? Ann Surg 2006; 244:663-667.
55. Jacquier I, Boutron I, Moher D, Roy C, Ravaud P. The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: A systematic review. Ann Surg 2006; 244:677-683.
56. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials E10. July 20, 2000.
57. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol 2001; 54:217-224.
58. Weijer C, Freedman B, Fuks A, Robbins J, Shapiro S, Skrutkowska M. What difference does it make to be treated in a clinical trial? A pilot study. Clin Invest Med 1996; 19:179-183.
59. Manchikanti L, Pampati V, Damron KS. The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005; 8:349-355.
60. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344:1594-1602.
61. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004; 256:91-100.
62. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: A review of the recent literature. Pain Pract 2007; 7:4-20.
63. Carette S, Leclaire R, Marcoux S, Morin F, Blaise G, St. Pierre A, Truchon R, Parent F, Levesque J, Bergeron V, Montminy P, Blanchette C. Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med 1997; 336:1634-1640.
64. Carette S, Marcoux S, Truchon R, Grondin C, Gagnon J, Allard Y, Latulippe M. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 1991; 325:1002-1007.
65. Karppinen J, Malmivaara A, Kurunlahti M, Kyllonen E, Pienimaki T, Nieminen P, Ohinmaa A, Tervonen O, Vanharanta H. Periradicular infiltration for sciatica. A randomized controlled trial. Spine 2001; 26:1059-1067.
66. Lord SM, Barnsley L, Wallis BJ, McDonald GJ, Bogduk N. Percutaneous radiofrequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med 1996; 5:1721-1726.
67. Riew KD, Park JB, Cho YS, Gilula L, Patel A, Lenke LG, Bridwell KH. Nerve root blocks in the treatment of lumbar radicular pain. A minimum five-year follow-up. J Bone Joint Surg Am 2006; 88:1722-1725.
68. Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C, Goette K. The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain. A prospective, randomized, controlled, double-blind study. J Bone Joint Surg Am 2000; 82-A:1589-1593.
69. Karppinen J, Ohinmaa A, Malmivaara A, Kurunlahti M, Kyllonen E, Pienimaki T, Nieminen P, Tervonen O, Vanharanta H. Cost effectiveness of periradicular infiltration for sciatica. Spine 2001; 26:2587-2595.
70. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: One-year follow-up of a randomized, double-blind controlled trial: Clinical Trial NCT00355914. Pain Physician 2008; 11:121-132.
71. Manchikanti L, Singh V, Falco FJ, Cash KM, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized, double-blind, controlled trial with 1-year follow-up. Spine 2008; 33:1813-1820.
72. Manchikanti L, Singh V, Falco FJ, Cash KM, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: A preliminary report of a randomized, double-blind controlled trial: Clinical Trial NCT00355706. Pain Physician 2008; 11:491-504.
73. Manchikanti L, Pampati V, Fellows B, Bakhit CE. The diagnostic validity and therapeutic value of lumbar facet joint nerve blocks with or without adjuvant agents. Curr Rev Pain 2000; 4:337-344.
74. Cuckler JM, Bernini PA, Wiesel SW, Booth RE Jr, Rothman RH, Pickens GT. The use of epidural steroid in the treatment of radicular pain. J Bone Joint Surg 1985; 67:63-66.
75. Manchikanti KN, Pampati V, Damron KS, McManus CD. A double-blind, controlled evaluation of the value of Sarapin in neural blockade. Pain Physician 2004; 7:59-62.
76. Leclaire R, Fortin L, Lambert R, Bergeron YM, Rossignol M. Radiofrequency facet joint nerve denervation in the treatment of low back pain: A placebo-controlled clinical trial to assess efficacy. Spine 2001; 26:1411-1416.
77. Manchikanti L, Pampati V, Rivera JJ, Beyer CD, Damron KS, Barnhill RC. Caudal epidural injections with Sarapin or steroids in chronic low back pain. Pain Physician 2001; 4:322-335.
78. Manchikanti L, Damron KS, Cash KA, Manchukonda R, Pampati V. Therapeutic medial branch blocks in managing chronic neck pain: A preliminary report of a randomized, double-blind, controlled trial: Clinical Trial NCT0033272. Pain Physician 2006; 9:333-346.
79. Manchikanti L, Singh V, Rivera JJ, Pampati V, Beyer CD, Damron KS, Barnhill RC. Effectiveness of caudal epidural injections in discogram positive and negative chronic low back pain. Pain Physician 2002; 5:18-29.
80. Manchikanti L. Interventional pain management: Past, present, and future. The Prithvi Raj lecture: Presented at the 4th World Congress-World Institute of Pain, Budapest, 2007. Pain Pract 2007; 7:357-371.
81. Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH. Randomized clinical trials: Perspectives on some recent ideas. N Engl J Med 1976; 295:74-80.
82. Feinstein AR. Current problems and future challenges in randomized clinical trials. Circulation 1984; 70:767-774.
83. Abel U, Koch A. The role of randomization in clinical studies: Myths and beliefs. J Clin Epidemiol 1999; 52:487-497.
84. Sacks H, Chalmers TC, Smith H Jr. Randomized versus historical controls for clinical trials. Am J Med 1982; 72:233-240.
85. Kane RL. Approaching the outcomes question. In Kane RL (ed). Understanding Health Care Outcomes Research. Aspen Publications, Gaithersburg, 1997, pp 1-15.
86. Shikata S, Nakayama T, Noguchi Y, Taji Y, Yamagishi H. Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg 2006; 244:668-676.
87. Groenwold RH, Van Deursen AM, Hoes AW, Hak E. Poor quality of reporting confounding bias in observational intervention studies: A systematic review. Ann Epidemiol 2008 Aug 8; [Epub ahead of print].
88. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. Int J Epidemiol 2007; 36:666-676.
89. Hartz A, Bentler S, Charlton M, Lanska D, Butani Y, Soomro GM, Benson K. Assessing observational studies of medical treatments. Emerg Themes Epidemiol 2005; 2:8.
90. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-1886.
91. Hartz A, Benson K, Glaser J, Bentler S, Bhandari M. Assessing observational studies of spinal fusion and chemonucleolysis. Spine 2003; 28:2268-2275.
92. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
93. Shrier I, Boivin JF, Steele RJ, Platt RW, Furlan A, Kakuma R, Brophy J, Rossignol M. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol 2007; 166:1203-1209.
94. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technol Assess 2007; 11:1-178.
95. Fleiss JL, Levin B, Paik MC. How to randomize. In Statistical Methods for Rates and Proportions. 3rd ed. John Wiley & Sons, Hoboken, 2003, pp 86-94.
96. Kang M, Ragan BG, Park JH. Issues in outcomes research: An overview of randomization techniques for clinical trials. J Athl Train 2008; 43:215-221.
97. Manchikanti L, Pampati V. Research designs in interventional pain management: Is randomization superior, desirable or essential? Pain Physician 2002; 5:275-284.
98. Dreyfuss P, Baker R. In response to treatment of neck pain. Eur Spine J 2008; 17:1270-1272.
99. Barnsley L. Percutaneous radiofrequency neurotomy for chronic neck pain: Outcomes in a series of consecutive patients. Pain Med 2005; 6:282-286.
100. Govind J, King W, Bailey B, Bogduk N. Radiofrequency neurotomy for the treatment of third occipital headache. J Neurol Neurosurg Psychiatr 2003; 74:88-93.
101. McDonald GJ, Lord SM, Bogduk N. Long term follow-up of patients treated with cervical radiofrequency neurotomy for chronic neck pain. Neurosurgery 1999; 45:61-67.
102. Sapir DA, Gorup JM. Radiofrequency medial branch neurotomy in litigant and nonlitigant patients with cervical whiplash. Spine 2001; 26:E268-E273.
103. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology Assessment No. 47. AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality, 2002. www.thecre.com/pdf/ahrq-system-strength. pdf
104. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282:1061-1066.
105. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 1995; 274:645-651.
106. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25.
107. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 2003; 49:1-6.
108. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
109. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006; 295:1152-1160.
110. Kunz R, Vist GE, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2007; MR000012.
111. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimen sions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-412.
112. Moher D. CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. JAMA 1998; 279:1489-1491.
113. Kjaergard LL, Nikolova D, Gluud C. Randomized clinical trial in hepatology: Predictors of quality. Hepatology 1999; 30:1134-1138.
114. Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001; 323:42-46.
115. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347:81-88.
116. Gillespie WJ. Arthroscopic surgery was not effective for relieving pain or improving function in osteoarthritis of the knee. ACP J Club 2003; 138:49.
117. Jackson RW. Arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347:1717-1719.
118. Morse LJ. Arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347:1717-1719.
119. Chambers KG, Schulzer M. Arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347:1717-1719.
120. Ellis TJ, Crawford D. Arthroscopic surgery for arthritis of the knee. Curr Womens Health Rep 2003; 3:63-64.
121. Ewing W, Ewing JW. Arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347:1717.
122. Kelly MA. Role of arthroscopic debridement in the arthritic knee. J Arthroplasty 2006; 21:9-10.
123. Poehling GG. Degenerative arthritis arthroscopy and research. Arthroscopy 2002; 18:683-687.
124. Siparsky P, Ryzewicz M, Peterson B, Bartz R. Arthroscopic treatment of osteoarthritis of the knee: Are there any evidence-based indications? Clin Orthop Relat Res 2007; 455:107-112.
125. Hawker G, Guan J, Judge A, Dieppe P. Knee arthroscopy in England and Ontario: Patterns of use, changes over time, and relationship to total knee joint replacement. J Bone Joint Surg A; in press.
126. Kirkley A, Birmingham TB, Litchfield RB, Giffin R, Willits KR, Wong CJ, Feagan BG, Donner A, Griffin SH, D'Ascanio LM, Pope JE, Fowler PJ. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2008: 359:1097-1107.
127. Felson DT, Buckwalter J. Debridement and lavage for osteoarthritis of the knee. N Engl J Med 2002; 347:132-133.
128. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91:660-673.
129. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. Am J Gastroenterol 1996; 91:277-283.
130. Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136:381-385.
131. Schor S, Karten I. Statistical evaluation of medical journal manuscripts. JAMA 1966; 195:1123-1128.
132. Gore SM, Jones IG, Rytter EC. Misuse of statistical methods: Critical assessment of articles in BMJ from January to March 1976. Br Med J 1977; 1:85-87.
133. Hall JC, Hill D, Watts JM. Misuse of statistical methods in the Australasian surgical literature. Aust N Z J Surg 1982; 52:541-543.
134. Altman DG. Statistics in medical journals. Stat Med 1982; 1:59-71.
135. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987; 317:426-432.
136. Altman DG. The scandal of poor medical research. BMJ 1994; 308:283-284.
137. Moher D, Jones A, Lepage L, CONSORT Group (Consolidated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA 2001; 285:1992-1995.
138. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust 2006; 185:263-267.
139. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: A survey of journal editors and journal 'Instructions to Authors'. Trials 2008; 9:20.
140. Prady SL, Richmond SJ, Morton VM, MacPherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS ONE 2008; 3:e1577.
141. de Vet HCW, de Bie RA, van der Heijden GJMG, Verhagen AP, Sijpkes P, Kipschild PG. Systematic reviews on the basis of methodological criteria. Physiotherapy 1997; 83:284-289.
142. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2:31-49.
143. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986; 4:942-951.
144. van der Heijden GJ, van der Windt DA, Kleijnen J, Koes BW, Bouter LM. Steroid injections for shoulder disorders: A systematic review of randomized clinical trials. Brit J Gen Pract 1996; 46:309-316.
145. Sindhu F, Carpenter L, Seers K. Development of a tool to rate the quality assessment of randomized controlled trials using a Delphi technique. J Adv Nurs 1997; 25:1262-1268.
146. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52:377-384.
147. Reisch JS, Tyson JE, Mize SG. Aid to the evaluation of therapeutic studies. Pediatrics 1989; 84:815-827.
148. Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K. Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer. Evidence Report/Technology Assessment No. 4. Rockville, MD. Agency for Health Care Policy and Research. AHCPR Publication No.99-E0012; 1999.
149. Lau J, Ioannidis J, Balk E, Milch C, Chew P, Terrin N, Lang TA, Salem D, Wong JB. Evaluating Ischemia in Emergency De partments: Evidence Report/Technology Assessment: No. 26. Rockville, MD. Agency for Healthcare Research and Quality. AHRQ Publication No. 01-E006 (Contract 290-97-0019 to the New England Medical Center); 2000.
150. Chestnut RM, Carney N, Maynard H, Patterson P, Mann NC, Helfand M. Rehabilitation for Traumatic Brain Injury. Evidence Report/Technology Assessment No. 2. Rockville, MD. Agency for Health Care Policy and Research. AHCPR Publication No. 99-E006; 1999.
151. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology Assessment No. 11. Rockville, MD. Agency for Health care Research and Quality. AHRQ Publication No. 00-E005; 1999.
152. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, Hlatky MA. An Evaluation of Beta-Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina. Rockville, MD. Agency for Healthcare Research and Quality. AHRQ Publication No. 00-E003; 1999.
153. Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE. Treatment of Depression: Newer Pharmacotherapies. Evidence Report/Technology Assessment No. 7. Rockville, MD. Agency for Health Care Policy and Research. AHRQ Publication No. 00-E003; 1999.
154. Vickrey BG, Shekelle P, Morton S, Clark K, Pathak M, Kamberg C. Prevention and Management of Urinary Tract Infections in Paralyzed Persons. Evidence Report/Technology Assessment No. 6. Rockville, MD. Agency for Health Care Policy and Research. AHCPR Publication No. 99-E008; 1999.
155. West SL, Garbutt JC, Carey TS, Lux LJ, Jackman AM, Tolleson-Rinehart S, Lohr KN, Crews FT. Pharmacotherapy for Alcohol Dependence. Evidence Report/ Technology Assessment No. 5; Rockville, MD. Agency for Health Care Policy and Research. AHCPR Publication No. 99-E004; 1999.
156. McNamara RL, Miller MR, Segal JB, Goodman SN, Kim NL, Robinson KA, Powe NR. Management of New Onset Atrial Fibrillation. Evidence Report/Technology Assessment No. 12. Rockville, MD. Agency for Health Care Policy and Research; AHRQ Publication No. 01-E026; 2001.
157. Ross S, Eston R, Chopra S, French J. Management of Newly Diagnosed Patients With Epilepsy: A Systematic Review of the Literature. Evidence Report/Technology Assessment No. 39; Rockville, MD. Agency for Healthcare Research and Quality. AHRQ Publication No. 01-E-029; 2001.
158. Goudas L, Carr DB, Bloch R, Balk E, Ioannidis JPA, Terrin N, Gialeli-Goudas M, Chew P, Lau J. Management of Cancer Pain. Evidence Report/Technology Assessment. No. 35 (Contract 290-97-0019 to the New England Medical Center). Rockville, MD. Agency for Health Care Policy and Research. AHCPR Publication No. 99-E004; 2000.
159. Nelemans P, deBie R, deVet H, Sturmans F. WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain. Cochrane Database Syst Rev 2007; 3:CD001824.
160. Koes BW, Scholten RJ, Mens JMA, Bouter LM. Epidural steroid injections
161. Manchikanti L, Rivera JJ, Pampati V, Damron KS, McManus CD, Brandon DE, Wilson SR. One day lumbar epidural adhesiolysis and hypertonic saline neurolysis in treatment of chronic low back pain: A randomized, double-blind trial. Pain Physician 2004; 7:177-186.
162. Manchikanti L, Boswell MV, Rivera JJ, Pampati V, Damron KS, McManus CD, Brandon DE, Wilson SR. A randomized, controlled trial of spinal endoscopic adhesiolysis in chronic refractory low back and lower extremity pain. BMC Anesthesiol 2005; 5:10.
163. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials. Increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290:1624-1632.
164. Roland M, Torgerson DJ. What are pragmatic trials? BMJ 1998; 316:285.
165. Barbui C, Hotopf M. Forty years of antidepressant drug trials. Acta Psychiatr Scand 2001; 104:92-95.
166. Vesely AE, De Almeida J. Evidence-Based Medicine: Part 1: More than just the randomized controlled trial. Univ Toronto Med J 2002; 2:129-132.
167. Cohen MA. MAST: What went wrong? An essay on the changes in medical practice. Pharos Alph Omega Alpha Honor Med Soc 2000; 63:22-26.
168. Holmberg L, Baum M, Adami HO. On the scientific inference from clinical trials. J Eval Clin Pract 1999; 5:157-162.
169. Maisonneuve H, Ojasoo T. From the life cycles of clinical evidence to the learning curve of clinical experience. J Eval Clin Pract 1999; 5:417-421.
170. Knottnerus A, Dinant GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997; 315:1109-1110.
171. Smith BH. Evidence based medicine. Quality cannot always be quantified. BMJ 1995; 311:258.
172. Rosser WW. Application of evidence from randomised controlled trials to general practice. Lancet 1999; 353:661-664.
173. Norman GR. Examining the assumptions of evidence-based medicine. J Eval Clin Pract 1999; 5:139-147.
174. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352:609-613.
175. Kirk-Smith MD, Stretch DD. Evidence-based medicine and randomized double-blind clinical trials: A study of flawed implementation. J Eval Clin Pract 2001; 7:119-123.
176. Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999; 353: 743-743.
177. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Int Med 1996; 124:485-489.
178. Feinstein AR, Horwitz RI. Problems in the "evidence" of "evidence-based medicine." Am J Med 1997; 103:529-535.
179. Djulbegovic B, Morris L, Lyman GH. Evidentiary challenges to evidence-based medicine. J Eval Clin Pract 2000; 6:99-109.
180. Charlton BG. Evidence based medicine. Megatrials are subordinate to medical science. BMJ 1995; 311:257.
181. Owens DK. Response: Does the emperor have new clothes? Pharos Alpha Omega Alpha Honor Med Soc 2000: 63:29-30.
182. Siderowf AD. Evidence from clinical trials: Can we do better? NeuroRx 2004; 1:363-371.
183. Investigational New Drug Application. Code of Federal Regulations Title 21 Part 5, pp 300-499. Revised as of 4-1-1999. Government Printing Office, Washington, DC, 1999.
184. Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D. Central challenges facing the national clinical research enterprise. JAMA 2003; 289:1278-1287.
185. MacPherson H. Pragmatic clinical trials. Complement Ther Med 2004; 12:136-140.
186. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992; 327:765-771.
187. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furier KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P, Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345:1444-1451.
188. McBride R, Anderson DC, Asinger RW, Newburg SM, Farmer CC, Wang K, Bundlie SR, Koller RL, Jagiella WM, Kreher S, Jorgensen CR, Sharkey SW, Flaker GC, Webel R, Nolte B, Stevenson P, Byer J, Wright W, Chesebro JH. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322:863-868.
189. Chesebro JH, Wiebers DO, Holland AE, Linker S, Bardsley WT, Kopecky S, Litin SC, Meissner I, Zerbe DM, Flaker GC, Webel R, Nolte B, Stevenson P, Byer J, Jenkins JS, Wright W, Anderson DC, Asinger RW, Newburg SM. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343:687-691.
190. Vist GE, Hagen KB, Devereaux PJ, Bryant D, Kristoffersen DT, Oxman AD. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev 2007; MR000009.
191. King M, Nazareth I, Lamper F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. Health Technol Assess 2005; 9:1-186.
192. Rendell JM, Merritt RD, Geddes JR. Incentives and disincentives to participation by clinicians in randomised controlled trials. Cochrane Database Syst Rev 2007; MR000021.
193. van Kleef M, Barendse GA, Kessels A, Voets HM, Weber WE, de Lange S. Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine 1999; 24:1937-1942.
194. Nath S, Nath CA, Pettersson K. Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain. A randomized double-blind trial. Spine 2008; 33:1291-1297.
195. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007; 132:179-188.
196. Kemler MA, Barendse GAM, van Kleef M, deVet HC, Rijks CP, Furnée CA, van den Wildenberg FA. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000; 343:618-624.
197. North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: A randomized, controlled trial. Neurosurgery 2005; 56:98-107.
198. Malmivaara A, Slätis P, Heliövaara M, Sainio P, Kinnunen H, Kankare J, Dalin-Hirvonen N, Seitsalo S, Herno A, Kortekangas P, Niinimäki T, Rönty H, Tallroth K, Turunen V, Knekt P, Härkänen T, Hurri H; Finnish Lumbar Spinal Research Group. Surgical or nonoperative treatment for lumbar spinal stenosis? A randomized controlled trial. Spine 2007; 32:1-8.
199. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, Abdu WA, Hilibrand AS, Boden SD, Deyo RA. Surgical vs nonoperative treatment for lumbar disk herniation: The Spine Patient Outcomes Research Trial (SPORT): A randomized trial. JAMA 2006; 296:2441-2450.
200. Stadhouder A, Buskens E, de Klerk LW, Verhaar JA, Dhert WA, Verbout AJ, Vaccaro AR, Oner FC. Traumatic thoracic and lumbar spinal fractures: Operative or nonoperative treatment: Comparison of two treatment strategies by means of surgeon equipoise. Spine 2008; 33:1006-1017.
201. Fritzell P, Wessberg P, Nordwall A: Swedish Lumbar Spine Study Group. Chronic low back pain and fusion: A comparison of three surgical techniques: A prospective multicenter randomized study from the Swedish lumbar spine study group. Spine 2002; 27:1131-1141.
202. Mirza SK, Deyo RA. Systematic review of randomized trials comparing lumbar fusion surgery to nonoperative care for treatment of chronic back pain. Spine 2007; 32:816-823.
203. Tosteson AN, Skinner JS, Tosteson TD, Lurie JD, Andersson GB, Berven S, Grove MR, Hanscom B, Blood EA, Weinstein JN. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: Evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine 2008; 33:2108-2115.
204. Day SJ, Altman DG. Statistics notes: Blinding in clinical trials and other studies. BMJ 2000; 321:504.
205. Poolman RW, Struijs PA, Krips R, Sierevelt IN, Marti RK, Farrokhyar F, Bhandari M. Reporting of outcomes in orthopaedic randomized trials: Does blinding of outcome assessors matter? J Bone Joint Surg Am 2007; 89:550-558.
206. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Guyatt GH. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001; 285:2000-2003.
207. Andrew E, Anis A, Chalmers T, Cho M, Clarke M, Felson D, Gotzsche P, Greene R, Jadad A, Jonas W, Klassen T, Knipschild P, Laupacis A, Meinert CL, Moher D, Nichol G, Oxman A, Penman MF, Pocock S. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272:1926-1931.
208. Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: Survey of published parallel group trials in obstetrics and gynaecology. BMJ 1996; 312:742-744.
209. DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med 1982; 306:1332-1337.
210. Cheng K, Smyth RL, Motley J, O'Hea U, Ashby D. Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatr Pulmonol 2000; 29:1-7.
211. Gøtzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989; 10:31-56.
212. Lang T. Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate. MedGenMed 2000; 2:E25.
213. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133:245-252.
214. Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. Validity of clinical trials of antidepressants. Am J Psychiatry 2000; 157:327-337.
215. Carragee EJ, Hurwitz EL, Cheng I, Carroll LJ, Nordin M, Guzman J, Peloso P, Holm LW, Côté P, Hogg-Johnson S, van der Velde G, Cassidy JD, Haldeman S, Secretariat of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. The authors' reply to the letter to the editor by Paul Dreyfuss et al. Eur Spine J 2008; 17:1273-1275.
216. Lachin JM, Matts JP, Wei LJ, Randomization in clinical trials: Conclusions and recommendations. Control Clin Trials 1988; 9:365-374.
217. Schulz KF. Randomized controlled trials. Clin Obstet Gynecol 1998; 41:245-256.
218. Armitage P. The role of randomization in clinical trials. Stat Med 1982; 1:345-352.
219. Greenland S. Randomization, statistics, and causal inference. Epidemiology 1990; 1:421-429.
220. Kleijnen J, Gøtzsche P, Kunz RA, Oxman AD, Chalmers I. So what's so special about randomisation. In Maynard A, Chalmers I (eds). Non-Random Reflections on Health Services Research: On the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency. BMJ Publishers, London, 1997, pp 93-106.
221. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994; 272:125-128.
222. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990; 335:149-153.
223. Altman DG, Bland JM. How to randomise. BMJ 1999; 319:703-704.
224. Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274:1456-1458.
225. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: Chance, not choice. Lancet 2002;359:515-519.
226. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, Sackett DL, Cinà CS, Walter SD, Haynes B, Schünemann HJ, Norman GR, Guyatt GH. Need for expertise based randomised controlled trials. BMJ 2005;330:88.
227. Enas GG, Enas NH, Spradlin CT, Wilson MG, Wiltse CG. Baseline comparability in clinical trials. Drug Inf J 1990; 24:541-548.
228. Altman DG. Randomisation. BMJ 1991; 302:1481-1482.
229. Hedden SL, Woolson RF, Malcolm RJ. Randomization in substance abuse clinical trials. Subst Abuse Treat Prev Policy 2006; 1:6.
230. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
231. McEntegart DJ. The pursuit of balance using stratified and dynamic randomization techniques: An overview. Drug Inf J 2003; 37:293-308.
232. Pocock SJ. Clinical Trials: A Practical Approach. John Wiley & Sons Ltd, Chichester, 1983.
233. Treasure T, MacRae KD. Minimisation: The platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 1998; 317:362-363.
234. Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health 2004; 94:416-422.
235. Cornfield J. Randomization by group: A formal analysis. Am J Epidemiol 1978;108:100-102.
236. COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): 1. Cohort results from a four-year community intervention. Am J Public Health 1995; 85:183-192.
237. Halloran ME, Longini IM Jr, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev 1999;21:73-88.
238. Weir CJ, Lees KR. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Stat Med 2003; 22:705-726.
239. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control Clin Trials 2002; 23:662-674.
240. Bracken MB. On stratification, minimization and protection against types 1 and 2 error. J Clin Epidemiol 2001;54:104-105.
241. Frane JW. A method of biased coin randomization, its implementation, and its validation. Drug Inf J 1998; 32:423-432.
242. Taves DR. Minimization: A new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974; 15:443-453.
243. Begg CB, Iglewicz B. A treatment allocation procedure for sequential clinical trials. Biometrics 1980; 36:81-90.
244. Rosenberger WF. Randomized playthe-winner clinical trials: Review and recommendations. Control Clin Trials 1999; 20:328-342.
245. Kang M, Ragan BG, Park JH. Issues in outcomes research: An overview of randomization techniques for clinical trials. J Athl Train 2008; 43:215-221.
246. Bandyopadhyay U, Biswas A, Bhattacharya R. A covariate adjusted twostage allocation design for binary responses in randomized clinical trials. Stat Med 2007; 26:4386-4399.
247. Berger VW. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials. Biom J 2005; 47:119-127.
248. Kuehn BM. Industry, FDA warm to "adaptive" trials. JAMA 2006; 296:1955-1957.
249. Schmidt C. Adaptive design may hasten clinical trials. J Natl Cancer Inst 2007; 99:108-109.
250. Morita S, Sakamoto J. Application of an adaptive design to a randomized phase II selection trial in gastric cancer: A report of the study design. Pharm Stat 2006; 5:109-118.
251. Goldberg HI, McGough H. The ethics of ongoing randomization trials: Investigation among intimates. Med Care 1991; 29:JS41-JS48.
252. Abraham NS, Young JM, Solomon MJ. A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials. Surgery 2006; 139:469-483.
253. King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Impact of participant and physician intervention preferences on randomized trials: A systematic review. JAMA 2005; 293:1089-1099.
254. Torgerson DJ, Sibbald B. Understanding controlled trials. What is a patient preference trial? BMJ 1998; 316:360.
255. Torgerson DJ, Klaber-Moffett J, Russell IT. Patient preferences in randomised trials: Threat or opportunity? J Health Serv Res Policy 1996; 1:194-197.
256. Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol 2003; 56:109-115.
257. Jadad A. Randomized Controlled Trials: A User's Guide. BMJ Books, London, 1998.
258. Adamson J, Cockayne S, Puffer S, Torgerson DJ. Review of randomised trials using the post-randomised consent (Zelen's) design. Contemp Clin Trials 2006; 27:305-319.
259. Torgerson DJ, Roland M. What is Zelen's design? BMJ 1998; 316:606.
260. Wennberg JE, Barry MJ, Fowler FJ, Mulley A. Outcomes research, PORTS, and health care reform. Ann NY Acad Sci 1993; 703:52-62.
261. Pildal J, Chan AW, Hrobjartsson A, Forfang E, Altman DG, Gotzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: Cohort study. BMJ 2005; 330;1049.
262. Forder PM, Gebski VJ, Keech AC. Allocation concealment and blinding: When ignorance is bliss. Med J Aust 2005; 182:87-89.
263. Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. Metaanalysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. Stat Med 1987; 6:315-328.
264. Schulz KF, Grimes DA. Allocation concealment in randomized trials: Defending against deciphering. Lancet 2002; 359:614-618.
265. Pocock SJ. Statistical aspects of clinical trial design. Statistician 1982; 31:1-18.
266. Wittink H, Turk DC, Carr DB, Sukiennik A, Rogers W. Comparison of the redundancy, reliability, and responsiveness to change among SF-36, Oswestry Disability Index, and Multidimensional Pain Inventory. Clin J Pain 2004; 20:133-142.
267. Turk DC, Melzack R. The measurement of pain and the assessment of people experiencing pain. In Turk DC, Melzack R (eds). Handbook of Pain Assessment. 2nd ed. Guilford, New York, 2001, pp 13-14.
268. Rogers W, Wittink H, Wagner A, Cynn D, Carr DB. Assessing individual outcomes during outpatient, multidisciplinary chronic pain treatment by means of an augmented SF-36. Pain Med 2000; 1:44-54.
269. Fairbank J, Couper J, Davies J, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271-273.
270. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23:345-356.
271. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
272. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000; 25:2940-2952.
273. Deyo RA, Battie M, Beurskens AJ, Bombardier C, Croft P, Koes B, Malmivaara A, Roland M, Von Korff M, Waddell G. Outcomes measures for low back pain research: A proposal for standardized use. Spine 1998; 23:2003-2013.
274. Roland M, Morris R. A study of the natural history of low back pain. Part 1: Development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8:141-144.
275. Vernon H, Mior S. The Neck Disability Index: A study of reliability and validity. J Manipulative Physiol Ther 1991; 14:409-415.
276. Pietrobon R, Coeytaux RR, Carey TS, Richardson WJ, DeVellis RF. Standard scales for measurement of functional outcome for cervical pain or dysfunction. Spine 2002; 27:515-522.
277. Stratford PW, Riddle DL, Binkley JM, Spadoni G, Westaway MD, Padfield B. Using the Neck Disability Index to make decisions concerning individual patients. Physiother Can 1999; 51:107-112.
278. Trouli MN, Vernon HT, Kakavelakis KN, Antonopoulou MD, Paganas AN, Lionis CD. Translation of the Neck Disability Index and validation of the Greek version in a sample of neck pain patients. BMC Musculoskeletal Disord 2008;9:106.
279. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975; 1:277-299.
280. Ware JE. The status of health assessment 1994. Ann Rev Public Health 1995; 16:327-354.
281. World Health Organization. Constitution of the WHO, Basic Documents. 1948.
282. Kuenstner S, Langelotz C, Budach V, Possinger K, Krause B, Sezer O. The comparability of quality of life scores: A multitrait multimethod analysis of the EORTC QOL-C30, SF-36 and FLIC questionnaires. Eur J Cancer 2002; 38:339-348.
283. Ware JE. SF-36 Health Survey Update. Spine 2000; 25:3130-3139.
284. Measuring and reporting pain outcomes in randomized controlled trials. Blue Cross Blue Shield Association. Technology Evaluation Center. Assessment Program. Volume 21, No. 11, October 2006.
285. Nielsen CS, Price DD, Vassend O, Stubhaug A, Harris JR. Characterizing individual differences in heat-pain sensitivity. Pain 2005; 119:65-74.
286. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In Turk DC, Melzack R (eds). Handbook of Pain Assessment, 2nd Edition. Guilford Press, New York, 2001, pp 15-34.
287. Gracely RH, Kwilosz DM. The descriptor differential scale: Applying psychophysical principles to clinical pain assessment. Pain 1988; 35:279-288.
288. Leavitt F, Garron DC, Whisler WW, Sheinkop MB. Affective and sensory dimensions of back pain. Pain 1978; 4:273-281.
289. Schofferman J. Restoration of function: The missing link in pain medicine? Pain Med 2006; 7:S159-S165.
290. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17:45-56.
291. Grotle M, Brox JI, Vollestad NK. Concurrent comparison of responsiveness in pain and functional status measurements used for patients with low back pain. Spine 2004; 29:E492-E501.
292. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158.
293. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004;8:283-291.
294. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine 2005; 30:1331-1334.
295. van der Roer N, Ostelo RW, Bekkering GE, van Tulder MW, de Vet HC. Minimal clinically important change for pain intensity, functional status, and general health status in patients with non-specific low back pain. Spine 2006; 31:578-582.
296. Suarez-Almazor ME, Kendall C, Johnson JA, Skeith K, Vincent D. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxford) 2000; 39:783-790.
297. van der Windt DA, van der Heijden GJ, de Winter AF, Koes BW, Deville W, Bouter LM. The responsiveness of the Shoulder Disability Questionnaire. Ann Rheum Dis 1998; 57:82-87.
298. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000; 27:2683-2691.
299. Hanley MA, Jensen MP, Ehde DM, Robinson LR, Cardenas DD, Turner JA, Smith DG. Clinically significant change in pain intensity ratings in persons with spinal cord injury or amputation. Clin J Pain 2006; 22:25-31.
300. Spadoni GF, Stratford PW, Solomon PE, Wishart LR. The evaluation of change in pain intensity: A comparison of the P4 and single-item numeric pain rating scales. J Orthop Sports Phys Ther 2004; 34:187-193.
301. Smidt N, van der Windt DA, Assendelft WJ, Mourits AJ, Deville WL, de Winter AF, Bouter LM. Interobserver reproducibility of the assessment of severity of complaints, grip strength, and pressure pain threshold in patients with lateral epicondylitis. Arch Phys Med Rehabil 2002; 83:1145-1150.
302. Hagg O, Fritzell P, Nordwall A, Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003; 12:12-20.
303. Beurskens AJ, de Vet HC, Koke AJ. Responsiveness of functional status in low back pain: A comparison of different instruments. Pain 1996; 65:71-76.
304. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: The minimal clinically important improvement. Ann Rheum Dis 2005; 64:29-33.
305. Crossley KM, Bennell KL, Cowan SM, Green S. Analysis of outcome measures for persons with patellofemoral pain: Which are reliable and valid? Arch Phys Med Rehabil 2004; 85:815-822.
306. Auleley GR, Benbouazza K, Spoorenberg A, Collantes E, Hajjaj-Hassouni N, van der Heijde D, Dougados M. Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis Rheum, 2002; 47:582-587.
307. Kropmans TJ, Dijkstra PU, Stegenga B, Stewart R, de Bont LG. Repeated assessment of temporomandibular joint pain: Reasoned decision-making with use of unidimensional and multidimensional pain scales. Clin J Pain 2002;18:107-115.
308. Hayes M, Patterson D. Experimental development of the graphic rating method. Psych Bull 1921; 18:98-99.
309. Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: Patient preference does not confound pain measurement. Pain 1981; 10:241-248.
310. Bonica JJ. Evolution and current status of pain programs. J Pain Symptom Manage 1990; 5:368-374.
311. Good M, Stiller C, Zausniewski JA, Anderson GC, Stanton-Hicks M, Grass JA. Sensation and Distress of Pain Scales: reliability, validity, and sensitivity. J Nurs Meas 2001; 9:219-238.
312. Manchikanti L, Manchikanti KN, Manchukonda R, Pampati V, Cash KA. Evaluation of therapeutic thoracic medial branch block effectiveness in chronic thoracic pain: A prospective outcome study with minimum 1-year follow up. Pain Physician 2006; 9:97-105.
313. Manchikanti L, Manchikanti KN, Damron KS, Pampati V. Effectiveness of cervical medial branch blocks in chronic neck pain: A prospective outcome study. Pain Physician 2004; 7:195-201.
314. Hansen HC, McKenzie-Brown AM, Cohen SP, Swicegood JR, Colson JD, Manchikanti L. Sacroiliac joint interventions: A systematic review. Pain Physician 2007; 10:165-184.
315. Buenaventura RM, Shah RV, Patel V, Benyamin R, Singh V. Systematic review of discography as a diagnostic test for spinal pain: An update. Pain Physician 2007; 10: 147-164.
316. Trescot AM, Chopra P, Abdi S, Datta S, Schultz DM. Systematic review of effectiveness and complications of adhesiolysis in the management of chronic spinal pain: An update. Pain Physician 2007; 10:129-146.
317. Datta S, Everett CR, Trescot AM, Schultz DM, Adlaka R, Abdi S, Atluri SL, Smith HS, Shah RV. An updated systematic review of diagnostic utility of selective nerve root blocks. Pain Physician 2007; 10:113-128.
318. Seghal N, Dunbar EE, Shah RV, Colson JD. Systematic review of diagnostic utility of facet (zygapophysial) joint injections in chronic spinal pain: An update. Pain Physician 2007; 10:213-228.
319. Abdi S, Datta S, Trescot AM, Schultz DM, Adlaka R, Atluri SL, Smith HS, Manchikanti L. Epidural steroids in the management of chronic spinal pain: A systematic review. Pain Physician 2007; 10:185-212.
320. Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R. A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician 2007; 10:229-253.
321. Barnsley L, Lord SM, Wallis BJ, Bogduk N. The prevalence of chronic cervical zygapophyseal joint pain after whiplash. Spine 1995; 20:20-26.
322. Barnsley L, Lord S, Wallis B, Bogduk N. False-positive rates of cervical zygapophysial joint blocks. Clin J Pain 1993; 9:124-130.
323. Lord SM, Barnsley L, Wallis BJ, Bogduk N. Chronic cervical zygapophysial joint pain with whiplash: A placebo-con trolled prevalence study. Spine 1996; 21:1737-1745.
324. Manchikanti L, Singh V, Pampati V, Damron KS, Beyer CD, Barnhill RC. Is there correlation of facet joint pain in lumbar and cervical spine? An evaluation of prevalence in combined chronic low back and neck pain. Pain Physician 2002; 5:365-371.
325. Manchikanti L, Singh V, Rivera J, Pampati V. Prevalence of cervical facet joint pain in chronic neck pain. Pain Physician 2002; 5:243-249.
326. Manchikanti L, Boswell MV, Singh V, Pampati V, Damron KS, Beyer CD. Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord 2004; 5:15.
327. Manchikanti L, Singh V, Pampati V, Beyer C, Damron K. Evaluation of the prevalence of facet joint pain in chronic thoracic pain. Pain Physician 2002; 5:354-359.
328. Manchukonda R, Manchikanti KN, Cash KA, Pampati V, Manchikanti L. Facet joint pain in chronic spinal pain: An evaluation of prevalence and false-positive rate of diagnostic blocks. J Spinal Disord Tech 2007; 20:539-545.
329. Manchikanti L, Manchikanti KN, Pampati V, Brandon DE, Giordano J. The prevalence of facet-joint-related chronic neck pain in postsurgical and non-postsurgical patients: A comparative evaluation. Pain Pract 2008; 8:5-10.
330. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. Clinical features of patients with pain stemming from the lumbar zygapophysial joints. Is the lumbar facet syndrome a clinical entity? Spine 1994; 19:1132-1137.
331. Schwarzer AC, Wang SC, Bogduk N, Mc-Naught PJ, Laurent R. Prevalence and clinical features of lumbar zygapophysial joint pain: A study in an Australian population with chronic low back pain. Ann Rheum Dis 1995; 54:100-106.
332. Manchikanti L, Singh V. Review of chronic low back pain of facet joint origin. Pain Physician 2002; 5:83-101.
333. Manchikanti L, Pampati V, Fellows B, Bakhit C. Prevalence of lumbar facet joint pain in chronic low back pain. Pain Physician 1999; 2:59-64.
334. Manchikanti L, Pampati V, Fellows B, Baha AG. The inability of the clinical picture to characterize pain from facet joints. Pain Physician 2000; 3:158-166.
335. Manchikanti L, Singh V, Pampati V, Damron K, Barnhill R, Beyer C, Cash K. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician 2001; 4:308-316.
336. Manchikanti L, Hirsch JA, Pampati V. Chronic low back pain of facet (zygapophysial) joint origin: Is there a difference based on involvement of single or multiple spinal regions? Pain Physician 2003; 6:399-405.
337. Manchikanti L, Manchukonda R, Pampati V, Damron KS, McManus CD. Prevalence of facet joint pain in chronic low back pain in postsurgical patients by controlled comparative local anesthetic blocks. Arch Phys Med Rehabil 2007; 88:449-455.
338. Pauza KJ, Howell S, Dreyfuss P. A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain. Spine J 2004; 4:27-35.
339. Turk DC. Statistical significance and clinical significance are not synonyms! Clin J Pain 2000; 16:185-187.
340. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain 2000; 88:287-294.
341. Middel B, Stewart R, Bouma J, van Sonderen E, van den Heuvel W. How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating? J Eval Clin Pract 2001;7:399-410.
342. Wyrwich KW, Wolinsky FD. Identifying meaningful intraindividual change standards for health-related quality of life measures. J Eval Clin Pract 2000;6:39-49.
343. Wyrwich K, Nienaber N, Tierney W, Wolinsky F. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-478.
344. Mikail SF, DuBreuil S, D'Eon JL. A comparative analysis of measures used in the assessment of chronic pain patients. Psychol Assess 1993; 5:117-120.
345. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiat 1961; 4:561-571.
346. Epker J, Gatchel RJ. Prediction of treatment-seeking behavior in acute TMD patients: Practical application in clinical settings. J Orofac Pain 2000; 14:303-309.
347. Olsson I, Bunketorp O, Carlsson SG, Styf J. Prediction of outcome in whiplash-associated disorders using West Haven-Yale Multidimensional Pain Inventory. Clin J Pain 2002;18:238-244.
348. Burton HJ, Kline SA, Hargadon R, Cooper BS, Schick R, Ong M. Assessing patients with chronic pain using the basic personality inventory as a complement to the multidimensional pain inventory. Pain Res Manag 1999; 4:121-129.
349. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002; 18:355-365.
350. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113:9-19.
351. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: Reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997; 50:79-93.
352. Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK. An empirical comparison of four generic health status measures: The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 1997; 35:522-537.
353. Bronfort G, Bouter LM. Responsiveness of general health status in chronic low back pain: A comparison of the COOP charts and the SF-36. Pain 1999; 83:201-209.
354. Kosinski M, Keller SD, Ware JE Jr., Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: Relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999; 37:MS23-MS39.
355. Roos EM, Klassbo M, Lohmander LS. WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis. Western Ontario and MacMaster Universities. Scand J Rheumatol 1999; 28:210-215.
356. Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J, Chambers WA, Smith WC. The Chronic Pain Grade questionnaire: Validation and reliability in postal research. Pain 1997; 71:141-147.
357. Elliott AM, Smith BH, Smith WC, Chambers WA. Changes in chronic pain severity over time: The Chronic Pain Grade as a valid measure. Pain 2000;88:303-308.
358. Haas M, Nyiendo J. Diagnostic utility of the McGill Pain Questionnaire and the Oswestry Disability Questionnaire for classification of low back syndromes. J Manipulative Physiol Ther 1992; 15:90-98.
359. Gronblad M, Hupli M, Wennerstrand P, Jarvinen E, Lukinmaa A, Kouri JP, Karaharju EO. Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993; 9:189-195.
360. Salen BA, Spangfort EV, Nygren AL, Nordemar R. The Disability Rating Index: An instrument for the assessment of disability in clinical settings. J Clin Epidemiol 1994; 47:1423-1435.
361. Strong J, Ashton R, Large RG. Function and the patient with chronic low back pain. Clin J Pain 1994; 10:191-196.
362. Greenough CG. Recovery from low back-pain: 1-5 year follow-up of 287 injury-related cases. Acta Orthop Scand Suppl 1993; 254:1-34.
363. Kaplan GM, Wurtele SK, Gillis D. Maximal effort during functional capacity evaluations: An examination of psychological factors. Arch Phys Med Rehabil 1996; 77:161-164.
364. Grevitt M, Khazim R, Webb J, Mulholland R, Shepperd J. The short form-36 health survey questionnaire in spine surgery. J Bone Joint Surg Br 1997; 79:48-52.
365. Loisel P, Poitras S, Lemaire J, Durand P, Southiere A, Abenhaim L. Is work status of low back pain patients best described by an automated device or by a questionnaire? Spine 1998; 23:1588-1594.
366. Nordin M, Skovron ML, Hiebert R, Weiser S, Brisson PM, Campello M, Harwood K, Crane M, Lewis S. Early predictors of delayed return to work in patients with low back pain. J Musculoskelet Pain 1997; 5:5-27.
367. Kaivanto KK, Estlander AM, Moneta GB, Vanharanta H. Isokinetic performance in low back-pain patients: The predictive power of the Self-Efficacy Scale. J Occup Rehabil 1995; 5:87-99.
368. Kuukkanen T, Malkia E. Muscular performance after a 3 month progressive physical exercise program and 9 month follow-up in subjects with low back pain. A controlled study. Scand J Med Sci Sports 1996; 6:112-121.
369. Fisher K, Johnson M. Validation of the Oswestry Low Back Pain Disability Questionnaire, its sensitivity as a measure of change following treatment and its relationship with other aspects of the chronic pain experience. Physiother Theory Pract 1997; 13:67-80.
370. Sufka A, Hauger B, Trenary M, Bishop B, Hagen A, Lozon R, Martens B. Centralization of low back pain and perceived functional outcome. J Orthop Sports Phys Ther 1998; 27:205-212.
371. Gronblad M, Jarvinen E, Hurri H, Hupli M, Karaharju EO. Relationship of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) with three dynamic physical tests in a group of patients with chronic lowback and leg pain. Clin J Pain 1994; 10:197-203.
372. Gronblad M, Hurri H, Kouri JP. Relationships between spinal mobility, physical performance tests, pain intensity and disability assessments in chronic low back pain patients. Scand J Rehabil Med 1997; 29:17-24.
373. Little D, MacDonald D. The use of the percentage change in Oswestry Disability Index Score as an outcome measure in lumbar spinal surgery. Spine 1994; 19:2139-2143.
374. Luoto S, Hupli M, Alaranta H, Hurri H. Isokinetic performance capacity trunk muscles. Part II. Coefficient of variation in isokinetic measurement in maximal effort and in submaximal effort. Scand J Rehabil Med 1996; 28:207-210.
375. Luoto S, Taimela S, Hurri H, Aalto H, Pyykko I, Alaranta H. Psychomotor speed and postural control in chronic low back pain patients: A controlled follow-up study. Spine 1996; 21:2621-2627.
376. Breitenseher MJ, Eyb RP, Matzner MP, Trattnig S, Kainberger FM, Imhof H. MRI of unfused lumbar segments after spondylodesis. J Compt Assist Tomogr 1996; 20:583-587.
377. Sanderson P, Todd B, Holt G, Getty CJ. Compensation, work status, disability in low back pain patients. Spine 1995; 20:554-556.
378. Roland M, Fairbank J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine 2000; 25:3115-3124.
379. Bergner M, Bobbitt R, Carter W, Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787-805.
380. Deyo R, Centor R. Assessing the responsiveness of functional scales to clinical change: An analogy to diagnostic test performance. J Chronic Dis 1986; 39:897-906.
381. Patrick D, Deyo R, Atlas S, Singer DE, Chapin A, Keller RB. Assessing health-related quality of life in patients with sciatica. Spine 1995; 20:1899-1908.
382. Jensen MP, Strom SE, Turner JA, Romano JM. Validity of the Sickness Impact Profile Roland Scale as a measure of dysfunction in chronic pain patients. Pain 1992; 50:157-162.
383. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L, Wood-Dauphinee S, Lamping DL, Williams JI. The Quebec Back Pain Disability Scale: Conceptualization and development. J Clin Epidemiol 1996; 49:151-161.
384. Leclaire R, Blier F, Fortin L, Proulx R. A cross-sectional study comparing the Oswestry and Roland-Morris functional disability scales in two populations of patients with low back pain of different levels of severity. Spine 1997; 22:68-71.
385. Stratford PW, Binkley J, Solomon P, Gill C, Finch E. Assessing change over time in patients with low-back-pain. Phys Ther 1994; 74:528-533.
386. Deyo RA. Measuring the functional status of patients with low-back pain. Arch Phys Med Rehabil 1988; 69:1044-1053.
387. Simmonds M, Olson S, Jones S, Hussein T, Lee CE, Novy D, Radwan H. Psychometric characteristics and clinical usefulness of physical performance tests in patients with low back pain. Spine 1998; 23:2412-2421.
388. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: Part 1. Phys Ther 1998; 78:1186-1196.
389. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L, Wood-Dauphinee S, Lamping DL, William JI. The Quebec Back Pain Disability Scale: Measurement properties. Spine 1995; 20:341-352.
390. Co YY, Eaton S, Maxwell MW. The relationship between the St. Thomas and Oswestry disability scores and the severity of low back pain. J Manipulative Physiol Ther 1993; 16:14-18.
391. Kopec J, Esdaile J. Functional disability scales for back pain. Spine 1995; 20:1943-1949.
392. Beurskens A, de Vet H, Koke A, van der Heijden GJ, Knipschild PG. Measuring functional status of patients with low back pain: Assessment of the quality of four disease specific questionnaires. Spine 1995; 20:1017-1728.
393. Frost H, Lamb SE, Stewart-Brown S. Responsiveness of a patient specific outcome measure compared with the Oswestry Disability Index V2.1 and Roland and Morris Disability Questionnaire for patients with subacute and chronic low back pain. Spine 2008; 33:2450-2457.
394. Wloduka-Demaille S, Poiraudeau S, Catanzariti JF, Rannou F, Fermanian J, Reve M. French translation and validation of 3 functional disability scales for neck pain. Arch Phys Med Rehabil 2002; 83:376-382.
395. Ackelman B, Lindgren U. Validity and reliability of a modified version of the Neck Disability Index. J Rehabil Med 2002; 34:284-287.
396. Vos CJ, Verhagen AP, Koes BW. Reliability and responsiveness of the Dutch version of the Neck Disability Index in patients with acute neck pain in general practice. Eur Spine J 2006; 11:1729-1736.
397. Cook C, Richardson JK, Braga L, Menezes A, Soler X, Kume P, Zaninelli M, Sokolows F, Pietrobon R. Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Neck Disability Index and Neck Pain and Disability Scale. Spine 2006; 31:1621-1627.
398. Cleland JA, Childs JD, Whitman JM. Psychometric properties of the Neck Disability Index and Numeric Pain Rating Scale in patients with mechanical neck pain. Arch Phys Med Rehabil 2008; 89:69-74.
399. Riddle D, Stratford P. Use of generic versus region-specific functional status measures on patients with cervical spine disorders. Phys Ther 1998; 78:951-963.
400. Jette DU, Jette AM. Physical therapy and health outcomes in patients with spinal impairments. Phys Ther 1996; 76:930-941.
401. Cleland JA, Fritz JM, Whitman JM, Palmer JA. The reliability and construct validity of the Neck Disability Index and Patient Specific Functional Scale in patients with cervical radiculopathy. Spine 2006; 31:598-602.
402. Pool JJ, Ostelo RW, Hoving JL, Bouter LM, de Vet HC. Minimal clinically important change of the Neck Disability Index and the Numerical Rating Scale for patients with neck pain. Spine 2007; 32:3047-3051.
403. Westaway M, Stratford P, Binkley J. The Patient-Specific Functional Scale: Validation of its use in persons with neck dysfunction. J Orthop Sports Phys Ther 1998; 27:331-338.
404. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407-415.
405. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56:395-407.
406. Bombardier C, Hayden J, Beaton DE. Minimal clinically important difference: Low back pain. Outcome measures. J Rheumatol 2001; 28:431-438.
407. Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 2003; 10:1128-1130.
408. Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, Brooks P, Tugwell P. Minimal clinically important differences: Review of methods. J Rheumatol 2001; 28:406-412.
409. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): A literature review and directions for future research. Curr Opin Rheumatol 2002; 14:109-114.
410. Riddle DL, Stratford PW, Binkley JM. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: Part 2. Phys Ther 1998; 78:1197-1207.
411. Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999; 130:995-1004.
412. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69:979-985.
413. Tannock IF. False-positive results in clinical trials: Multiple significance tests and the problem of unreported comparisons. J Natl Cancer Inst 1996; 88:206-207.
414. Streiner D, Norman G. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford University Press, New York, 1995.
415. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311:1145-1148.
416. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 311:485.
417. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272:122-124.
418. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978; 299:690-694.
419. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984; 3:409-422.
420. Eng J. Sample size estimation: How many individuals should be studied? Radiology 2003; 227:309-313.
421. Lerman J. Study design in clinical research: Sample size estimation and power analysis. Can J Anaesth 1996; 43:184-191.
422. Woodward M. Formulas for samplesize, power and minimum detectable relative risk in medical studies. Statistician 1992; 41:185-196.
423. Browner WS, Newman TB, Cummings SR, Hulley SB. Estimating sample size and power. In Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB (eds). Designing Clinical Research: An Epidemiologic Approach, 2nd ed. Lippincott, Williams & Wilkins, Philadelphia, 2001, pp 65-84.
424. Frison L, Pocock S. Repeated measurements in clinical trials: Analysis using mean summary statistics and its implications for design. Stat Med 1992; 11:1685-1704.
425. Rosner B. Estimation of sample size and power for comparing two means. In Fundamentals of Biostatistics. 5th ed. Duxbury Press, Pacific Grove, 2000, pp 307-308.
426. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. Wiley-Interscience, New York, 1981.
427. Pagano M, Gauvreau K. Principles of Biostatistics. 2nd ed. Duxbury Press, Pacific Grove, 2000.
428. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates, Hillsdale, 1988.
429. Lang TA, Secic M. How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers. American College of Physicians (ACP) Press, Philadelphia, 1997.
430. Whitley E, Ball J. Statistics review 4: Sample size calculations. Crit Care 2002; 6:335-341.
431. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. In Altman DG, Machin D, Bryant TN, Gardner MJ (eds). Statistics with Confidence: Confidence Intervals and Statistical Guidelines. 2nd edition. BMJ Books, London, 2000, pp 171-190.
432. Altman DG, Bland JM. Statistics notes. Units of analysis. BMJ 1997; 314:1874.
433. Bolton S. Independence and statistical inference in clinical trial designs: A tutorial review. J Clin Pharmacol 1998; 38:408-412.
434. Greenland S. Principles of multilevel modelling. Int J Epidemiol 2000; 29:158-167.
435. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine - reporting of subgroup analyses in clinical trials. N Engl J Med 2007; 357:2189-2194.
436. Rothwell PM. Treating individuals 2. Subgroup analysis in randomized controlled trials: Importance, indications, and interpretation. Lancet 2005; 365:176-186.
437. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991; 266:93-98.
438. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355:1064-1069.
439. Pocock SJ, Assmann SF, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med 2002; 21:2917-2930.
440. Hernández A, Boersma E, Murray G, Habbema J, Steyerberg E. Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading? Am Heart J 2006; 151:257-264.
441. Parker AB, Naylor CD. Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trials. Am Heart J 2000; 139:952-961.
442. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. N Engl J Med 2006; 354:1667-1669.
443. Halperin M, Ware JH, Byar DP. Testing for interaction in an IxJxK contingency table. Biometrika 1977; 64:271-275.
444. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41:361-372.
445. van Wijk RM, Geurts JW, Wynne HJ, Hammink E, Buskens E, Lousberg R, Knape JT, Groen GJ. Radiofrequency denervation of lumbar facet joints in the treatment of chronic low back pain: A randomized, double-blind, sham lesion-controlled trial. Clin J Pain 2005; 21:335-344.
446. van Wijk RM, Geurts JW, Lousberg R, Wynne HJ, Hammink E, Knape JT, Groen GJ. Psychological predictors of substantial pain reduction after minimally invasive radiofrequency and injection treatments for chronic low back pain. Pain Med 2008; 9:212-221.
447. Manchikanti L, Cash KA, Pampati V, Fellows B. Influence of psychological variables on the diagnosis of facet joint involvement in chronic spinal pain. Pain Physician 2008; 11:145-160.
448. Manchikanti L, Manchikanti K, Cash KA, Singh V, Giordano J. Age-related prevalence of facet joint involvement in chronic neck and low back pain. Pain Physician 2008; 11:67-75.
449. Vickers AJ. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BMC Med Res Methodol 2005; 5:35.
450. Altman DG. Practical Statistics for Medical Research. Chapman and Hall, London, 1991.
451. Jekel JF, Katz DL, Elmore JG. Epidemiology, Biostatistics and Preventive Medicine WB Saunders Company, Philadelphia, 2001.
452. Heeren T, D'Agostino R. Robustness of the two independent samples t-test when applied to ordinal scaled data. Stat Med 1987; 6:79-90.
453. Sawilowsky SS. Comments on using alternative to normal theory statistics in social and behavioural science. Canadian Psychology 1993; 34:432-439.
454. Zimmerman DW, Zumbo BD. The effect of outliers on the relative power of parametric and nonparametric statistical tests. Perceptual Mot Skills 1990; 71:339-349.
455. Sawilowsky SS, Blair RC. A more realistic look at the robustness and Type II error properties of the t-test to departures from population normality. Psychological Bulletin 1992; 111:352-360.
456. Bridge PD, Sawilowsky SS. Increasing physicians' awareness of the impact of statistics on research outcomes: Comparative power of the t-test and Wilcoxon Rank-Sum test in small samples applied research. J Clin Epidemiol 1999; 52:229-235.
457. Senn S. Statistical Issues in Drug Development. John Wiley & Sons Ltd, Chichester, 1997.
458. Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Med Res Methodol 2001; 1:6.
459. Kalish LA, Begg CB. Treatment allocation methods in clinical trials: A review. Stat Med 1985; 4:129-144.
460. Fisher R. Statistical Methods and Scientific Inference. 3rd ed. Macmillan, New York, 1973.
461. Browner W, Newman T. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. JAMA 1987; 257:2459-2463.
462. Diamond GA, Forrester JS. Clinical trials and statistical verdicts: Probable grounds for appeal. Ann Intern Med 1983; 98:385-394.
463. Lilford RJ, Braunholtz D. The statistical basis of public policy: A paradigm shift is overdue. BMJ 1996; 313:603-607.
464. Freeman PR. The role of p-values in analysing trial results. Stat Med 1993; 12:1443-1552.
465. Berkson J. Tests of significance considered as evidence. Journal of the American Statistical Association 1942; 37:325-335. Int J Epidemiol 2003; 32:687-691.
466. Pearson E. Student as a statistician. Biometrika 1938; 38:210-250.
467. Altman DG. Confidence intervals in research evaluation. Ann Intern Med 1992; 116:A28-A29.
468. Berry G. Statistical significance and confidence intervals. Med J Aust 1986; 144:618-619.
469. Braitman LE. Confidence intervals extract clinically useful information from data. Ann Intern Med 1988; 108:296-298.
470. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986; 105:429-435.
471. Godwin M. Hypothesis: The research page. Part 3: Power, sample size, and clinical significance. Can Fam Physician 2001; 47:1441-1443.
472. Altman DG, Bland J. Improving doctors' understanding of statistics. J R Statis Soc 1991; 154:223-267.
473. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multi-variable models. Ann Intern Med 1993; 118:201-210.
474. Altman DG, Goodman SN. Transfer of technology from statistical journals to the biomedical literature. Past trends and future predictions. JAMA 1994; 272:129-132.
475. Feinstein AR. P-values and confidence intervals: Two sides of the same unsatisfactory coin. J Clin Epidemiol 1998; 51:355-360.
476. Neyman J, Pearson E. On the problem of the most efficient tests of statistical hypotheses. Philos Trans R Soc, Series A 1933; 231:289-337.
477. Stallones RA. The use and abuse of subgroup analysis in epidemiological research. Prev Med 1987; 16:183-194.
478. Pocock SJ, Hughes MD. Estimation issues in clinical trials and overviews. Stat Med 1990; 9:657-671.
479. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: Quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001; 5:1-56.
480. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Clinical versus statistical considerations in the design and analysis of clinical research. J Clin Epidemiol 1998; 51:305-307.
481. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 2004; 57:229-236.
482. Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Med J Aust 2004; 180:289-291.
483. Matthews JNS, Altman DG. Interaction 2: Compare effect sizes not P values. BMJ 1996; 313:808.
484. Altman DG, Bland JM. Interaction revisited: The difference between two estimates. BMJ 2003; 326:219.
485. Wellek S. Testing Statistical Hypotheses of Equivalence. Chapman Hall/CRC Press, Boca Raton, 2003.
486. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med 1990; 113:69-76.
487. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. CMAJ 1994; 150:1611-1615.
488. Hartley J, Sydes M, Blurton A. Obtaining information accurately and quickly: Are structured abstracts more efficient? Journal of Information Science 1996; 22:349-356.
489. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277:925-926.
490. Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ 1996; 313:1390-1393.
491. Rodgers A, MacMahon S. Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: Implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost 1995; 73:167-171.
492. Fuks A, Weijer C, Freedman B, Shapiro S, Skrutkowska M, Riaz A. A study in contrasts: Eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. J Clin Epidemiol 1998; 51:69-79.
493. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Stat Med 1999; 18:2605-2615.
494. Rothmann M, Li N, Chen G, Chi GY, Temple R, Tsou HH. Design and analysis of non-inferiority mortality trials in oncology. Stat Med 2003; 22:239-264.
495. Egger M, Jüni P, Bartlett C, CONSORT Group (Consolidated Standards of Reporting of Trials). Value of flow diagrams in reports of randomized controlled trials. JAMA 2001; 285:1996-1999.
496. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol 1991; 9:191-192.
497. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72:511-518.
498. Pocock SJ. When to stop a clinical trial. BMJ 1992; 305:235-240.
499. Senn SJ. Base logic: Tests of baseline balance in randomized clinical trials. Clin Res Regul Aff 1995; 12:171-182.
500. Altman DG. Adjustment for covariate imbalance. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics. John Wiley & Sons, Chichester, 1998, pp 1000-1005.
501. Sheiner LB, Rubin DB. Intention-totreat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995; 57:6-15.
502. Nagelkerke N, Fidler V, Bernsen R, Borgdorff M. Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med 2000; 19:1849-1864.
503. Ruiz-Canela M, Mart?nez-Gonzalez MA, de Irala-Estevez J. Intention to treat analysis is related to methodological quality. BMJ 2000; 320:1007-1008.
504. Armitage P, Colton T. Encyclopedia of Biostatistics, John Wiley & Sons, New York, 1998.
505. Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Missing Data: The European Agency for the Evaluation of Medicinal Products. London, 2001.
506. Altman DG. Confidence intervals in practice. In Altman DG, Machin D, Bryant TN, Gardner MJ (eds). Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. BMJ Books, London, 2000, pp 6-14.
507. Altman DG. Clinical trials and meta-analyses. In Altman DG, Machin D, Bryant TN, Gardner MJ (eds). Statistics with Confidence: Confidence Intervals and Statistical Guidelines, 2nd ed. BMJ Books, London, 2000 pp 120-138.
508. Barron JP. Uniform requirements for manuscripts submitted to biomedical journals recommended by the International Committee of Medical Journal Editors. Chest 2006; 129:1098-1099.
509. Gardner MJ, Altman DG. Confidence intervals rather than P values: Estimation rather than hypothesis testing. Br Med J (Clin Res Ed) 1986; 292:746-750.
510. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication updated October 2004. Mymensingh Med J 2005; 14:95-119.
511. Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. JAMA 1997; 277:927-934.
512. Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. N Engl J Med 1997; 336:309-315.
513. Uniform requirements for manuscripts submitted to biomedical journals. Preface. Lancet 1979; 1:428-430.
514. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Applied Statistic 2000; 49:359-370.
515. Egger M, Dickersin K, Davey Smith G. Problems and limitations in conducting systematic reviews. In Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Publishing Group, London, 2001, pp 43-68.
516. Cook RJ, Sackett DL. The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995; 310:452-454.
517. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999; 319:1492-1495.
518. Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med 2000; 19:3325-3336.
519. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials. An evaluation of 7 medical areas. JAMA 2001; 285:437-443.
520. Horton R. The rhetoric of research. BMJ 1995; 310:985-987.
521. Annals of Internal Medicine. Information for authors. Available at www.annals.org.
522. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ 1999; 318:1224-1225.
523. Purcell GP, Donovan SL, Davidoff F. Changes to manuscripts during the editorial process: Characterizing the evolution of a clinical paper. JAMA 1998; 280:227-228.
524. Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet 1998; 351:321-325.
525. Campbell DT. Factors relevant to the validity of experiments in social settings. Psychol Bull 1957; 54:297-312.
526. McAlister FA. Applying the results of systematic reviews at the bedside. In Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Books, London, 2001, pp 373-385.
527. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318:1728-1733.